4.7 Article

Crizotinib induces pulmonary toxicity by blocking autophagy flux in alveolar epithelial cells

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Environmental Sciences

Polystyrene microplastic particles induce autophagic cell death in BEAS-2B human bronchial epithelial cells

Mi Seon Jeon et al.

Summary: The detection of high levels of microplastics in indoor and outdoor air has raised concerns about their toxic effects on the respiratory system. This study evaluated the inhalation toxicity of three differently charged polystyrene microplastics (PS-MPs) and found that the positively charged PS-MPs showed cytotoxicity and increased ROS generation in bronchial epithelial cells. Animal experiments also showed that only the positively charged PS-MPs significantly increased the expression and secretion of the pro-inflammatory cytokine IL-beta. The study suggests that inhalation of microplastics can induce autophagic cell death in bronchial epithelial cells, leading to inflammatory responses in the lungs.

ENVIRONMENTAL TOXICOLOGY (2023)

Article Cell Biology

Autophagic degradation of CCN2 (cellular communication network factor 2) causes cardiotoxicity of sunitinib

Zhifei Xu et al.

Summary: Excessive macroautophagy induced by sunitinib leads to apoptosis of cardiomyocytes and cardiac dysfunction through the TOLLIP-mediated endosome-related pathway. Additionally, deletion of Hmgb1 or treatment with the HMGB1-specific inhibitor glycyrrhizic acid can significantly mitigate sunitinib-induced autophagy, cardiomyocyte death, and cardiotoxicity. This study reveals a novel target protein of autophagic degradation in the regulation of cardiomyocyte death and suggests HMGB1 inhibition as a promising strategy for enhancing the safety of sunitinib-based cancer therapy.

AUTOPHAGY (2022)

Article Cell Biology

PLK1 (polo like kinase 1)-dependent autophagy facilitates gefitinib-induced hepatotoxicity by degrading COX6A1 (cytochrome c oxidase subunit 6A1)

Peihua Luo et al.

Summary: Liver dysfunction is a prominent dose-limiting toxicity of gefitinib, which activates autophagy and then apoptosis in hepatocytes. Autophagy is involved in gefitinib-induced hepatotoxicity, while PLK1 plays a crucial role in the autophagy-promoted apoptosis pathway. Pharmacological inhibition of PLK1 could be a promising therapeutic strategy to improve the safety of gefitinib-based cancer therapy.

AUTOPHAGY (2021)

Article Pharmacology & Pharmacy

The effect of metformin in EML4-ALK+ lung cancer alone and in combination with crizotinib in cell and rodent models

A. R. Bland et al.

Summary: Cell based studies have suggested that the combination of metformin with crizotinib may enhance the killing of ALK positive lung cancer cells and overcome crizotinib resistance. However, in vivo experiments using a xenograft mouse model showed that the combination did not result in greater tumor suppression compared to crizotinib alone. Additionally, metformin did not effectively overcome crizotinib resistance or directly induce cytotoxicity on cancer cells in this study.

BIOCHEMICAL PHARMACOLOGY (2021)

Article Oncology

Cancer Statistics, 2021

Rebecca L. Siegel et al.

Summary: Every year, the American Cancer Society projects the numbers of new cancer cases and deaths in the United States, with the latest data showing a significant decline in lung cancer mortality, while prostate cancer mortality has plateaued and breast and colorectal cancer mortality have slowed. Improvements in treatment have accelerated progress against lung cancer, leading to a record drop in overall cancer mortality.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Article Medicine, Research & Experimental

Bisdemethoxycurcumin alleviates vandetanib-induced cutaneous toxicity in vivo and in vitro through autophagy activation

Ying Jin et al.

Summary: The study demonstrated that vandetanib could induce cutaneous toxicity by promoting apoptosis, activating autophagy, causing mitochondrial damage, and inducing DNA damage. Bisdemethoxycurcumin partially reversed vandetanib-induced keratinocyte apoptosis by activating autophagy, thereby ameliorating cutaneous toxicity.

BIOMEDICINE & PHARMACOTHERAPY (2021)

Article Oncology

Crizotinib in Patients With MET-Amplified NSCLC

D. Ross Camidge et al.

Summary: The response to crizotinib in NSCLC patients with MET amplification is associated with the level of MET amplification. Patients with high-level MET amplification showed the highest objective response rate, suggesting a potential role of MET amplification in the treatment of NSCLC.

JOURNAL OF THORACIC ONCOLOGY (2021)

Article Toxicology

Crosstalk between alveolar macrophages and alveolar epithelial cells/fibroblasts contributes to the pulmonary toxicity of gefitinib

Jiangxia Du et al.

Summary: Gefitinib-induced pulmonary toxicity is characterized by the contribution of alveolar macrophages to promoting epithelial to mesenchymal transition in alveolar epithelial cells and inducing activation and antiapoptotic effect in fibroblasts, with MCP-1 playing a key role in the pathologic changes of these cell types. Inhibition of MCP-1 or STAT3 activation may serve as novel therapeutic strategies for preventing gefitinib-induced pulmonary toxicity.

TOXICOLOGY LETTERS (2021)

Article Multidisciplinary Sciences

Construction of a human cell landscape at single-cell level

Xiaoping Han et al.

NATURE (2020)

Review Pharmacology & Pharmacy

Macrophage M1/M2 polarization

Chen Yunna et al.

EUROPEAN JOURNAL OF PHARMACOLOGY (2020)

Review Medicine, Research & Experimental

Autophagy markers as mediators of lung injury-implication for therapeutic intervention

Selvaraj Vishnupriya et al.

LIFE SCIENCES (2020)

Article Pharmacology & Pharmacy

Macrophage-secreted TSLP and MMP9 promote bleomycin-induced pulmonary fibrosis

Guanqun Li et al.

TOXICOLOGY AND APPLIED PHARMACOLOGY (2019)

Review Pharmacology & Pharmacy

Pharmacology of metformin - An update

Hartmut H. Glossmann et al.

EUROPEAN JOURNAL OF PHARMACOLOGY (2019)

Review Respiratory System

Lung cancer and interstitial lung disease: a literature review

Jean-Marc Naccache et al.

JOURNAL OF THORACIC DISEASE (2018)

Article Multidisciplinary Sciences

AMPK contributes to autophagosome maturation and lysosomal fusion

Minsu Jang et al.

SCIENTIFIC REPORTS (2018)

Article Biochemistry & Molecular Biology

Metformin suppresses CRC growth by inducing apoptosis via ADORA1

Bin Lan et al.

FRONTIERS IN BIOSCIENCE-LANDMARK (2017)

Article Critical Care Medicine

Autophagy in Pulmonary Diseases

Kiichi Nakahira et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2016)

Review Oncology

Crizotinib in the Treatment of Non-Small-Cell Lung Cancer

Sacha I. Rothschild et al.

CLINICAL LUNG CANCER (2013)

Review Pharmacology & Pharmacy

Impairment of autophagy: From hereditary disorder to drug intoxication

Toshihiko Aki et al.

TOXICOLOGY (2013)

Review Respiratory System

Consensus statement for the diagnosis and treatment of drug-induced lung injuries

Keishi Kubo et al.

RESPIRATORY INVESTIGATION (2013)

Article Oncology

Lung Cancer: New Biological Insights and Recent Therapeutic Advances

Suresh S. Ramalingam et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2011)

Article Oncology

Targeting Anaplastic Lymphoma Kinase in Lung Cancer

Alice T. Shaw et al.

CLINICAL CANCER RESEARCH (2011)